Although the Government of Ontario removed mandatory masking requirements for most indoor settings March 21, 2022, this does not apply…
A year ago (March 10, 2021) we posted about adalimumab having five biosimilars, we are happy to say that number…
As a follow-up to our previous blog about the newly approved treatment for patients with psoriasis, we would like to…
Psoriasis is an autoimmune condition resulting in chronic inflammation of the skin affecting roughly 1 million Canadians. Mild to moderate…
We have spoken many times on our blog about the importance of mental health and how those living with chronic…
With the ongoing development of new advanced therapies (e.g. biologics and small molecule medications), most patients are able to achieve…
The team at Charlton Health would like to take this opportunity to wish you, your family, and friends all the…
On November 24th, Health Canada extended the approval for the non-live shingles vaccine known as SHINGRIX. Beyond the current approval for…
Medications provide great benefits for managing inflammatory bowel diseases (IBD) like Crohn’s disease and colitis, and will always be the…
As the focus on maintaining a low COVID-19 infection rate in our communities remains a priority, Ontario has made third…